Target intelligence / Profile preview

RNA, U6atac small nuclear 26, pseudogene (RNU6ATAC26P)

Target
RNU6ATAC26P
Molecular classification
Other (Pseudogene), Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U6atac small nuclear 26, pseudogene (RNU6ATAC26P) is a pseudogene that is related to the U6atac small nuclear RNA (snRNA) family, which is involved in the minor spliceosome machinery required for the splicing of a small class of introns known as U12-type introns[1][3]. However, as a pseudogene, RNU6ATAC26P is considered nonfunctional: it does not encode a functional protein or RNA product required for spliceosomal activity, and there is no evidence that it serves as a therapeutic target or has a defined molecular role in disease. Its main significance lies in genome annotation rather than functional genomics or biomedical relevance. There are no drugs, mechanism of action profiles, or safety issues associated with this entity. The presence of the term "pseudogene" means it has lost the function of the original gene. While some pseudogenes may be transcribed or even translated, this is rare and usually functionally irrelevant; there is no evidence that RNU6ATAC26P has such a role. This entity is not considered a druggable or therapeutic target and is not typically referenced in clinical or basic biomedical contexts[1][3][7].

Other names
RNU6ATAC26P
02

Biological functions

Other (pseudogene, not known to have a direct biological function)May serve as a non-coding RNA; canonical functionality essentially absent[1][3]
03

Disease associations

OtherNo known direct disease association or pathogenic role established for this pseudogene[1][3]

Beyond the preview

Go deeper on RNA, U6atac small nuclear 26, pseudogene (RNU6ATAC26P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6atac small nuclear 26, pseudogene (RNU6ATAC26P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call